Company Valuation: Alliance Pharma plc

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 444.1 466.6 585.4 286.2 218.9 223.8 - -
Change - 5.06% 25.47% -51.11% -23.53% 2.26% - -
Enterprise Value (EV) 1 503.3 576 672.4 388.2 310.1 298 274.3 243.4
Change - 14.44% 16.74% -42.26% -20.13% -3.89% -7.95% -11.25%
P/E ratio 17.8x 57.6x 80.6x 312x -6.61x 14.3x 11.1x 9.79x
PBR 1.62x 1.66x 2.07x 0.99x - 0.98x 0.82x 0.81x
PEG - -0.8x -7.2x -3.6x 0x -0x 0.4x 0.7x
Capitalization / Revenue 3.27x 3.59x 3.45x 1.66x 1.2x 1.18x 1.11x 1.06x
EV / Revenue 3.71x 4.44x 3.96x 2.26x 1.7x 1.58x 1.36x 1.15x
EV / EBITDA 12.8x 14.9x 13.8x 9.91x 6.89x 6.91x 5.92x 4.91x
EV / EBIT 13.4x 15.6x 14.7x 10.9x 7.41x 7.42x 6.33x 5.23x
EV / FCF 17.3x 16.9x 20.3x 24.6x 10.1x 11.4x 9.22x 7.78x
FCF Yield 5.78% 5.92% 4.93% 4.07% 9.91% 8.76% 10.8% 12.9%
Dividend per Share 2 0.00536 0.0161 0.0169 0.0178 - 0.00447 0.00476 -
Rate of return 0.64% 1.84% 1.55% 3.35% - 1.08% 1.15% -
EPS 2 0.0472 0.0152 0.0135 0.0017 -0.0613 0.0289 0.0373 0.0423
Distribution rate 11.4% 106% 125% 1,045% - 15.5% 12.8% -
Net sales 1 135.6 129.8 169.6 172 182.7 189 202 211
EBITDA 1 39.4 38.6 48.57 39.19 44.99 43.1 46.37 49.61
EBIT 1 37.45 36.83 45.64 35.67 41.86 40.18 43.3 46.52
Net income 1 25.01 8.027 7.319 0.936 -33.14 15.8 20.12 22.9
Net Debt 1 59.2 109.4 87 102 91.21 74.2 50.5 19.64
Reference price 2 0.8410 0.8760 1.0880 0.5300 0.4050 0.4140 0.4140 0.4140
Nbr of stocks (in thousands) 528,077 532,606 538,045 539,995 540,390 540,566 - -
Announcement Date 07/04/20 23/03/21 22/03/22 21/03/23 19/06/24 - - -
1GBP in Million2GBP
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
14.34x1.58x6.91x+1.08%296M
39.08x7.95x28.89x+0.75%52.65B
18.44x1.69x8.41x+1.55%30.01B
26.78x2.02x10.29x+1.52%17.67B
28.4x4.55x18.08x+0.61%15.94B
23.99x4.7x16.17x+0.55%12.99B
11.79x2.04x8.13x+4.14%6.39B
32.38x3.12x16.67x+0.19%5.55B
Average 24.40x 3.46x 14.19x +1.30% 17.69B
Weighted average by Cap. 29.03x 4.73x 18.38x +1.11%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. APH Stock
  4. Valuation Alliance Pharma plc
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW